This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of West Pharmaceutical Services Inc. (WST) slipped 1.09% to $312.71 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&amp;P 500 Index rising 0.02% to 7,520.36 and the Dow Jones Industrial Average rising 0.36% to 50,644.28.
This was the stock's second consecutive day of losses.
West Pharmaceutical Services Inc. closed 5.49% below its 52-week high of $330.88, which the company reached on May 11th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Abbott Laboratories (ABT) fell 1.14% to $85.68, Becton Dickinson &amp; Co. (BDX) fell 0.35% to $147.24, and Baxter International Inc. (BAX) fell 0.26% to $19.33.
Trading volume (652,286) remained 236,099 below its 50-day average volume of 888,385.
Data source: Dow Jones Market Data, FactSet. Data compiled May 27, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-27-26 1705ET

West Pharmaceutical Services Inc. (WST) shares fell 1.09% to $312.71, marking its second consecutive day of losses, despite a positive overall market. The stock is 5.49% below its 52-week high of $330.88. Competitors Abbott Laboratories, Becton Dickinson, and Baxter International also experienced declines. Trading volume was below the 50-day average.

MarketWatch Automated

West Pharmaceutical

S&P 500

Dow Jones Industrial Average

West Pharmaceutical Services Inc. Stock Outperforms Competitors Despite Losses On The Day